patent/WO-9633747-A3

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18773e0994d80743ef5939ace79050bb
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate	1996-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aceb24561717abc45e128108c777e501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a16f1b17a609884aa6323125636fd9
publicationDate	1997-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-9633747-A3
titleOfInvention	Water soluble fluorinated fatty acid sulfonate derivatives useful as magnetic resonance imaging agents
abstract	The present invention relates to improved imaging agents useful for 19F magnetic resonance imaging (MRI). More particularly, the present invention relates to fluorinated fatty acid sulfonate derivatives, such as those derived by reaction of fluorinated fatty acids with sulfonated compounds such as taurine analogs or isethionic acid analogs, which offer improved water solubility and biocompatibility.
priorityDate	1995-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-622246-A5 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9101759-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0250955-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425035971 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489743 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7866 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1123

Total number of triples: 23.